Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,803 | 243 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43.89 | 2 | 1.1% |
| Education | $26.77 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $642.53 | 59 | $0 (2020) |
| Novo Nordisk Inc | $556.20 | 46 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $449.19 | 28 | $0 (2020) |
| Lilly USA, LLC | $279.49 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $258.27 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $183.23 | 8 | $0 (2020) |
| PFIZER INC. | $175.40 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $173.04 | 13 | $0 (2021) |
| Abbott Laboratories | $163.17 | 9 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $130.12 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.12 | 6 | Lilly USA, LLC ($50.71) |
| 2023 | $41.81 | 2 | Lilly USA, LLC ($25.91) |
| 2022 | $158.22 | 9 | Abbott Laboratories ($89.84) |
| 2021 | $242.65 | 15 | PFIZER INC. ($50.18) |
| 2020 | $452.06 | 22 | GlaxoSmithKline, LLC. ($113.46) |
| 2019 | $785.15 | 63 | Sunovion Pharmaceuticals Inc. ($117.11) |
| 2018 | $1,104 | 66 | Janssen Pharmaceuticals, Inc ($267.89) |
| 2017 | $976.18 | 67 | Janssen Pharmaceuticals, Inc ($221.65) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 08/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes Care | ||||||
| 02/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes Care | ||||||
| 02/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Diabetes Care | ||||||
| 01/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes Care | ||||||
| 01/11/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes Care | ||||||
| 01/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardio-renal | ||||||
| 11/09/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/06/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes Care | ||||||
| 09/23/2021 | Eisai Inc. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Neurology | ||||||
| 08/30/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes Care | ||||||
| 07/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 05/27/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,530 | 2,350 | $370,270 | $196,335 |
| 2022 | 28 | 2,228 | 3,515 | $517,406 | $262,391 |
| 2021 | 27 | 2,283 | 3,452 | $486,943 | $253,218 |
| 2020 | 26 | 2,285 | 4,148 | $595,186 | $297,766 |
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 228 | 237 | $65,125 | $34,057 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 452 | $71,367 | $30,712 | 43.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 168 | 339 | $49,586 | $27,785 | 56.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 83 | 220 | $32,076 | $18,161 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $15,980 | $12,332 | 77.2% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 40 | 85 | $21,200 | $12,105 | 57.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 92 | 92 | $8,860 | $6,974 | 78.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 50 | 91 | $10,145 | $5,283 | 52.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 31 | 48 | $9,700 | $4,623 | 47.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 31 | 36 | $7,260 | $4,028 | 55.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 59 | $7,375 | $3,713 | 50.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 34 | 35 | $7,725 | $3,706 | 48.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 45 | 65 | $7,240 | $3,532 | 48.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 23 | 24 | $6,600 | $3,521 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 75 | $8,370 | $3,159 | 37.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $4,400 | $3,143 | 71.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 96 | $4,121 | $2,986 | 72.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 24 | $6,000 | $2,605 | 43.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,900 | $1,957 | 39.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 19 | 19 | $2,964 | $1,883 | 63.5% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 30 | $4,550 | $1,753 | 38.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 12 | 14 | $2,800 | $1,730 | 61.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 15 | 16 | $3,600 | $1,719 | 47.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 26 | 27 | $2,420 | $1,586 | 65.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $2,061 | $1,243 | 60.3% |
About Dr. Muhammad Waseem, MD
Dr. Muhammad Waseem, MD is a Internal Medicine healthcare provider based in Hagerstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184665143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Waseem, MD has received a total of $3,874 in payments from pharmaceutical and medical device companies, with $113.12 received in 2024. These payments were reported across 250 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,803).
As a Medicare-enrolled provider, Waseem has provided services to 8,326 Medicare beneficiaries, totaling 13,465 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hagerstown, MD
- Active Since 06/09/2006
- Last Updated 07/01/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184665143
Products in Payments
- XARELTO (Drug) $497.91
- APTIOM (Drug) $268.63
- TRELEGY ELLIPTA (Drug) $244.43
- ENTRESTO (Drug) $173.04
- Victoza (Drug) $161.88
- Ozempic (Drug) $145.76
- INVOKANA (Drug) $144.62
- Tresiba (Drug) $142.85
- NUEDEXTA (Drug) $130.12
- TRULICITY (Drug) $125.69
- TOUJEO (Drug) $122.42
- CHANTIX (Drug) $114.55
- Solitaire (Device) $96.88
- FREESTYLE LIBRE 2 (Device) $89.84
- ELIQUIS (Drug) $75.09
- Vascepa (Drug) $70.69
- UTIBRON (Drug) $70.22
- BROVANA (Drug) $70.09
- JARDIANCE (Drug) $53.93
- Rybelsus (Drug) $48.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hagerstown
Adam Gerstenblith, Md, MD
Internal Medicine — Payments: $294,244
Christopher Vaccari, M.d, M.D
Internal Medicine — Payments: $58,882
Mary Howell, Md, MD
Internal Medicine — Payments: $35,983
Michael Mccormack, M.d, M.D
Internal Medicine — Payments: $23,820
Imtiaz Khurshid, Md, MD
Internal Medicine — Payments: $7,597
Dr. Syed Mahmood, M.d, M.D
Internal Medicine — Payments: $4,713